Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-FR Version v9-EN
Language French English
Date Updated 2019-12-23 2019-03-15
Drug Identification Number 02331705 02331705
Brand name APO-VENLAFAXINE XR APO-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR VENLAFAXINE XR
Company Name APOTEX INC APOTEX INC
Ingredients VENLAFAXINE VENLAFAXINE
Strength(s) 150.0MG 150.0MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-12-10 2018-12-10
Actual start date 2018-12-11 2018-12-11
Estimated end date Unknown 2019-04-30
Actual end date 2019-12-20
Shortage status Resolved Actual shortage
Company comments
Health Canada comments